Literature DB >> 26162437

Epigenetics and systemic sclerosis.

Nezam Altorok1, Bashar Kahaleh.   

Abstract

Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by vascular injury, activation of the immune system, and diffuse tissue fibrosis. The precise etiology of SSc is undetermined, but there is evidence suggestive of a connection between environmental factors and SSc pathogenesis. In general, harmful environmental factors are sensed by the epigenetic regulatory mechanisms that alter host gene expression leading to the emergence of disease-specific phenotype. There are three epigenetic mechanisms involved in gene regulation: DNA methylation, histone modifications, and microRNAs. Although there is evidence that SSc phenotype could be, to a some degree, determined by genetic variants, it is clear now that non-genetic factors outweigh the genetic risk in SSc. Accordingly, the environment can trigger epigenetic regulation that in turn establishes a molecular framework linking environmental exposures to genetics, leading to the disease process, possibly in a genetically predisposed host. Although we have just begun to appreciate the potential role of epigenetics in SSc, many important and promising clues have been observed. In this review, we will summarize the work that has been done in the field of epigenetic regulation in SSc, and we will discuss possible factors and mechanisms that may lead to epigenetic dysregulation in SSc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26162437     DOI: 10.1007/s00281-015-0504-6

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  67 in total

1.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.

Authors:  Takaomi Sing; Masatoshi Jinnin; Keitaro Yamane; Norihito Honda; Kastunari Makino; Ikko Kajihara; Takamitsu Makino; Keisuke Sakai; Shinichi Masuguchi; Satoshi Fukushima; Hironobu Ihn
Journal:  Rheumatology (Oxford)       Date:  2012-06-01       Impact factor: 7.580

3.  Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis.

Authors:  HongYan Jiang; Rong Xiao; XiaoRi Lian; Takuro Kanekura; YangYang Luo; YongXing Yin; GuiYing Zhang; Yan Yang; YaoYao Wang; Ming Zhao; QianJin Lu
Journal:  Clin Immunol       Date:  2012-01-18       Impact factor: 3.969

4.  Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

5.  Benzene exposure and systemic sclerosis.

Authors:  L Czirják; G Szegedi
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

Review 6.  Scleroderma: from cell and molecular mechanisms to disease models.

Authors:  David J Abraham; John Varga
Journal:  Trends Immunol       Date:  2005-09-15       Impact factor: 16.687

7.  Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies.

Authors:  Carol Feghali-Bostwick; Thomas A Medsger; Timothy M Wright
Journal:  Arthritis Rheum       Date:  2003-07

8.  Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition.

Authors:  David Egging; Ivonne van Vlijmen-Willems; Tomas van Tongeren; Joost Schalkwijk; Anita Peeters
Journal:  Connect Tissue Res       Date:  2007       Impact factor: 3.417

9.  Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin.

Authors:  Masahide Kubo; Joanna Czuwara-Ladykowska; Omar Moussa; Margaret Markiewicz; Edwin Smith; Richard M Silver; Stefania Jablonska; Maria Blaszczyk; Dennis K Watson; Maria Trojanowska
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Demethylation of CD40LG on the inactive X in T cells from women with lupus.

Authors:  Qianjin Lu; Ailing Wu; Laura Tesmer; Donna Ray; Neda Yousif; Bruce Richardson
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

View more
  5 in total

Review 1.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

2.  Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.

Authors:  Ye He; Pei-Suen Tsou; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2018-05-14       Impact factor: 19.103

3.  Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Gloria Ravegnini; Maria-Cristina Arcangeletti; Clara Maccari; Flora De Conto; Adriana Calderaro; Elisabetta Caselli
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

4.  Metallopeptidades 2 and 9 genes epigenetically modulate equine endometrial fibrosis.

Authors:  Joana Alpoim-Moreira; Carina Fernandes; Jorge Pimenta; Miguel Bliebernicht; Maria Rosa Rebordão; Pedro Castelo-Branco; Anna Szóstek-Mioduchowska; Dariusz J Skarzynski; Graça Ferreira-Dias
Journal:  Front Vet Sci       Date:  2022-08-12

5.  Epigenetic down-regulation of microRNA-126 in scleroderma endothelial cells is associated with impaired responses to VEGF and defective angiogenesis.

Authors:  Yongqing Wang; John Sun; Bashar Kahaleh
Journal:  J Cell Mol Med       Date:  2021-06-17       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.